Search

Scolistin 4.5 MIU Injection – Colistimethate Sodium

Scolistin 4.5 MIU Injection contains Colistimethate Sodium 4.5 Million IU per vial. It is a sterile powder for solution for intramuscular and intravenous administration. This prescription antibiotic is used under medical supervision for selected serious infections caused by susceptible Gram-negative bacteria.

Key Features:

  • Brand: Scolistin

  • Composition: Colistimethate Sodium

  • Strength: 4.5 Million IU

  • Dosage Form: Powder for Injection

  • Administration: Intramuscular / Intravenous

  • Manufacturer: Medizia Biotech

  • Marketed by: Scotmed Care (P) Limited

For prescription use only. Administer under qualified medical supervision.

Scolistin 4.5 MIU Injection is a pharmaceutical formulation containing Colistimethate Sodium 4.5 Million International Units (IU) per vial. It is supplied as a sterile powder for solution for injection and is intended for intramuscular or intravenous administration under medical supervision.

Colistimethate Sodium belongs to the polymyxin class of antibiotics. It is used by healthcare professionals for managing certain serious bacterial infections caused by susceptible Gram-negative bacteria. Its use requires careful clinical assessment, appropriate microbiological testing and monitoring.

Marketed by Scotmed Care (P) Limited under the brand name Scolistin, this product is part of the company’s anti-infective pharmaceutical portfolio.

For product specifications, institutional requirements and business enquiries, contact Scotmed Care.Product Specifications

Specification Details
Brand name Scolistin
Generic name Colistimethate Sodium
Composition Sterile Colistimethate Sodium
Strength 4.5 Million IU
Dosage form Powder for solution for injection
Administration Intramuscular / Intravenous
Packaging Vial
Product category Anti-Infective Range
Marketed by Scotmed Care (P) Limited
Manufactured by Medizia Biotech
Prescription status Prescription-only medicine

Product information is based on the supplied packaging. Confirm the final product specifications and approved product information before publication.

What Is Scolistin 4.5 MIU Injection?

Scolistin 4.5 MIU Injection contains Colistimethate Sodium, an antibiotic belonging to the polymyxin group.

Colistimethate Sodium is a prodrug that converts into active colistin in the body. It works by disrupting the bacterial cell membrane, which can result in bacterial cell damage and death.

It is an important antibiotic option in selected serious infections involving susceptible Gram-negative bacteria, particularly when other treatment options may be limited.

The choice of treatment depends on the infecting organism, antimicrobial susceptibility results, patient condition and the treating physician’s assessment.

Composition of Scolistin 4.5 MIU Injection

Each vial contains:

  • Active ingredient: Sterile Colistimethate Sodium.

  • Strength: 4,500,000 International Units (IU).

The product is supplied as a powder that requires appropriate reconstitution before administration.

The preparation and administration must follow the approved product information and institutional protocols.

How Does Colistimethate Sodium Work?

Colistimethate Sodium is converted into active colistin in the body.

Colistin acts on the outer and inner membranes of susceptible Gram-negative bacteria. It interacts with membrane components, affecting membrane integrity and increasing bacterial cell permeability.

This mechanism can cause the leakage of essential cellular contents and ultimately lead to bacterial cell death.

Its activity is dependent on the susceptibility of the causative bacteria. Therefore, appropriate microbiological testing plays an important role in treatment decisions.

Clinical Applications of Colistimethate Sodium

Colistimethate Sodium may be considered by healthcare professionals for certain serious infections caused by susceptible Gram-negative bacteria.

Depending on the organism, infection site and clinical circumstances, these may include:

  • Selected respiratory tract infections.

  • Certain hospital-acquired bacterial infections.

  • Selected bloodstream infections.

  • Complicated urinary tract infections.

  • Serious infections involving susceptible Pseudomonas aeruginosa and other susceptible Gram-negative organisms.

Important: These are general clinical contexts associated with colistimethate sodium. They are not a claim that Scolistin 4.5 MIU is approved for every condition listed. Treatment must be based on the product’s approved prescribing information and medical judgement.

Important Safety Information

Colistimethate Sodium is a potent antibiotic that requires careful medical supervision.

Renal monitoring: Colistimethate Sodium can cause kidney-related adverse effects. Renal function should be assessed and monitored during treatment.

Neurological effects: Neurological reactions, including tingling, dizziness and muscle weakness, may occur.

Electrolyte monitoring: Healthcare professionals may need to monitor electrolyte levels during treatment.

Antimicrobial resistance: The medicine should only be used when there is an appropriate clinical indication involving susceptible or strongly suspected bacterial infections.

Administration: Reconstitution, dosage and administration must be determined by qualified healthcare professionals according to approved prescribing information.

Do not use this medicine without a valid prescription.

Why Choose Scotmed Care for Scolistin 4.5 MIU?

Scotmed Care (P) Limited offers a portfolio of injectable pharmaceutical formulations across different therapeutic categories.

Scolistin 4.5 MIU Injection is included in its anti-infective product portfolio.

For hospitals, pharmaceutical distributors, institutional buyers and healthcare procurement teams, Scotmed Care provides a point of contact for product-related enquiries.

You can contact the company for:

  • Product specifications and availability.

  • Institutional and bulk supply enquiries.

  • Pharmaceutical distribution requirements.

  • Product portfolio information.

  • Business and partnership enquiries.

For further information, visit the Scotmed Care Products Catalogue or contact the company directly.

Product Enquiry – Scolistin 4.5 MIU Injection

Looking for Scolistin 4.5 MIU Injection for institutional or pharmaceutical business requirements?

Contact Scotmed Care (P) Limited for product information, availability and commercial enquiries.

For product availability, pricing and supply conditions, please contact the company.

FAQs for SEO and AI Search

These FAQs are written to answer specific searches naturally. They should appear on the product page as visible content.

1. What is Scolistin 4.5 MIU Injection used for?

Scolistin 4.5 MIU Injection contains Colistimethate Sodium, an antibiotic used under medical supervision for selected serious infections caused by susceptible Gram-negative bacteria.

2. What is the generic name of Scolistin Injection?

The generic name of Scolistin Injection is Colistimethate Sodium.

3. What is the strength of Scolistin 4.5 MIU Injection?

Each vial contains Colistimethate Sodium equivalent to 4.5 Million International Units (IU), as stated on the product packaging.

4. What type of antibiotic is Colistimethate Sodium?

Colistimethate Sodium belongs to the polymyxin group of antibiotics. It is used against certain susceptible Gram-negative bacteria.

5. How is Scolistin 4.5 MIU Injection administered?

The product packaging specifies intramuscular and intravenous administration. It must be prepared and administered by qualified healthcare professionals.

6. Which bacteria can Colistimethate Sodium act against?

Depending on susceptibility, colistimethate sodium may act against certain Gram-negative bacteria, including Pseudomonas aeruginosa, Escherichia coli and Klebsiella pneumoniae.

7. Does Colistimethate Sodium require kidney function monitoring?

Yes. Colistimethate Sodium can affect kidney function. Healthcare professionals should monitor renal function and adjust treatment according to the patient’s clinical condition.

8. What are the important precautions associated with Scolistin Injection?

Important precautions include monitoring kidney function, neurological symptoms and electrolyte levels. Appropriate antimicrobial susceptibility testing should also guide its use.

9. Who manufactures Scolistin 4.5 MIU Injection?

The supplied product packaging identifies Medizia Biotech as the manufacturer and Scotmed Care (P) Limited as the company associated with the Scolistin brand.

10. How can I enquire about Scolistin 4.5 MIU Injection from Scotmed Care?

Hospitals, distributors and institutional buyers can contact Scotmed Care through its official website, email or telephone numbers for product specifications, availability and commercial enquiries.

Content missing

Scroll to Top